ACTIVE_NOT_RECRUITING

Mindfulness-oriented Recovery Enhancement (MORE) for Cancer Pain Relief

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of this study is to evaluate whether or not mindfulness-based interventions/MBIs may help reduce chronic pain in participants who have cancer-related chronic pain. MBIs are therapeutic programs that use mindfulness meditation practices to help people focus on the present moment, as well as encourage acceptance of thoughts, emotions, and body sensations. The researchers think that an MBI treatment called Mindfulness-oriented Recovery Enhancement (MORE) may help people who are experiencing cancer-related chronic pain.

Official Title

Adapting Mindfulness-oriented Recovery Enhancement (MORE) for Cancer Pain Relief: The MORE Relief Trial

Quick Facts

Study Start:2023-05-16
Study Completion:2027-05-16
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:ACTIVE_NOT_RECRUITING

Study ID

NCT05877521

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * English speaking
  2. * Age ≥ 18 years or older
  3. * A history of cancer with no restrictions placed on type of cancer
  4. * Determined to be either no-evidence of disease or stable oncological disease by referring or study physicians/advanced practice providers
  5. * Having a pain (musculoskeletal, generalized, or neuropathic) rating of 4 or greater in worst pain on a 0-10 numerical rating scale in the preceding week
  6. * Having had pain for at least 3 months and at least 15 days with pain in the preceding 30 days
  7. * Willing to adhere to all study-related procedures, including randomization to one of two treatment arms: MORE or WLC
  8. * Ability to attend video-call session and a quiet/private location
  1. * Active suicidality or schizophrenia
  2. * Plan to initiate palliative radiation or interventional pain procedure within the next 12 weeks
  3. * Cognitive impairment preventing completing PRO independently or participate in virtual MORE as evaluated by study clinicians

Contacts and Locations

Principal Investigator

Jun Mao, MD, MSCE
PRINCIPAL_INVESTIGATOR
Memorial Sloan Kettering Cancer Center

Study Locations (Sites)

Memorial Sloan Kettering Cancer Center (All Protocol Activities)
New York, New York, 10065
United States

Collaborators and Investigators

Sponsor: Memorial Sloan Kettering Cancer Center

  • Jun Mao, MD, MSCE, PRINCIPAL_INVESTIGATOR, Memorial Sloan Kettering Cancer Center

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-05-16
Study Completion Date2027-05-16

Study Record Updates

Study Start Date2023-05-16
Study Completion Date2027-05-16

Terms related to this study

Keywords Provided by Researchers

  • chronic pain
  • cancer pain
  • Mindfulness-oriented Recovery Enhancement
  • MORE
  • mindfulness-based interventions
  • MBIs
  • Memorial Sloan Kettering Cancer Center
  • 23-082

Additional Relevant MeSH Terms

  • Chronic Pain
  • Cancer Pain